The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

/C O R R E C T I O N -- Perrigo Company/

Thursday, October 24, 2013

/C O R R E C T I O N -- Perrigo Company/

08:23 EDT Thursday, October 24, 2013

In the news release, Perrigo Company To Release First Quarter Fiscal Year 2014 Results On October 31, 2013, issued Oct. 24, 2013 by Perrigo Company over PR Newswire, we are advised by the company that the first paragraph, second sentence, should read "The Company will conduct a conference call at 11:00 a.m. (ET)" rather than "9:00 a.m. (ET)" as originally issued inadvertently. The complete, corrected release follows:

Perrigo Company To Release First Quarter Fiscal Year 2014 Results On October 31, 2013

ALLEGAN, Mich., Oct. 24, 2013 /PRNewswire/ -- Perrigo Company (NYSE: PRGO;TASE:) today announced that it will release financial results for its first quarter fiscal year 2014  on Thursday, October 31, 2013 at approximately 8:00 a.m. (ET). The Company will conduct a conference call at 11:00 a.m. (ET) hosted by Joseph C. Papa, Perrigo's Chairman, President and Chief Executive Officer.

(Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO )

The conference call will be available live via webcast to interested parties in the investor relations section of the Perrigo website at http://perrigo.investorroom.com/events-webcasts or by phone at 877-248-9413, International 973-582-2737, and reference ID#75354490. A taped replay of the call will be available beginning at approximately 1:00 p.m. (ET) Thursday, October 31, until midnight Friday, November 8, 2013. To listen to the replay, dial 855-859-2056, International 404-537-3406, and use access code 75354490.

From its beginnings as a packager of generic home remedies in 1887, Perrigo Company, based in Allegan, Michigan, has grown to become a leading global healthcare supplier. The Company develops, manufactures and distributes over-the-counter ("OTC") and generic prescription ("Rx") pharmaceuticals, nutritional products and active pharmaceutical ingredients ("API") and is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. Perrigo's mission is to offer uncompromised "quality, affordable healthcare products", and it does so across a wide variety of product categories primarily in the United States, United Kingdom, Mexico, Israel and Australia, as well as certain other markets throughout the world, including Canada, China and Latin America. Visit Perrigo on the Internet (http://www.perrigo.com).

SOURCE Perrigo Company

For further information: Arthur J. Shannon, Vice President, Investor Relations and Global Communications (269) 686-1709; e-mail: ajshannon@perrigo.com, Bradley Joseph, Director, Investor Relations and Global Communications, (269) 686-3373; e-mail: bradley.joseph@perrigo.com

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Customer Service
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections